US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

10.04

-0.1900-1.86%

Post-market: 10.040.00000.00%19:37 EDT

Volume:163.90K

Turnover:1.68M

Market Cap:303.76M

PE:-1.73

High:10.69

Open:10.35

Low:10.00

Close:10.23

52wk High:11.80

52wk Low:5.60

Shares:30.26M

Float Shares:12.40M

Volume Ratio:0.86

T/O Rate:1.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.7983

EPS(LYR):-5.0200

ROE:-7029.26%

ROA:-17.43%

PB:-2.43

PE(LYR):-2.00

Loading ...

Overview Company News Filings

Wall Street Analysts Are Bullish on Top Healthcare Picks

Cartesian Therapeutics Price Target Maintained with a $38.00/Share by Wedbush

Cantor Fitzgerald Keeps Their Buy Rating on Cartesian Therapeutics (RNAC)

Cartesian Therapeutics Grants New Hires Stock Options for 115,250 Shares Under Inducement Plan

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics: Late-Stage Descartes-08 De-Risking and 2027 Data Wave Underpin Van Buren’s Buy Rating

Lineage Cell Therapeutics Q2 Revenue Falls but Posts Profit

Cartesian Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Cartesian Therapeutics Q2 2026 earnings: R&D spending rises as Phase 3 advances

Cartesian Therapeutics Q2 EPS $0.46 Beats $(0.86) Estimate

Benzinga Earnings

Cartesian Therapeutics Q2 FY26 Net Income Slips 0.74% to $15.8 Million

Cartesian Therapeutics Inc Q2 Operating Income USD -29.155 Million

THOMSON REUTERS

Cartesian Therapeutics: Phase 3 Aurora Trial of Descartes-08 in Myasthenia Gravis Data Expected in 1Q27, Bla Planned for Mid-2027

THOMSON REUTERS

Press Release: Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Cartesian Therapeutics Inc Expected to Post a Loss of 87 Cents a Share - Earnings Preview

Cartesian Therapeutics Grants Inducement Stock Options for 238,700 Shares at $10.18 to New Hires

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics (RNAC) Receives a Rating Update from a Top Analyst

Cartesian Therapeutics Shareholders Back Directors and Governance Measures

Cartesian Therapeutics shareholders elect Class I director slate at annual meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/RNAC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RNAC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAC\",,,,,undefined,":{"symbol":"RNAC","market":"US","secType":"STK","nameCN":"Cartesian Therapeutics","latestPrice":10.04,"timestamp":1787342400000,"preClose":10.23,"halted":0,"volume":163904,"hourTrading":{"tag":"盘后","latestPrice":10.04,"preClose":10.04,"latestTime":"19:37 EDT","volume":482,"amount":4850.16,"timestamp":1787355428409,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.018572825024438053,"floatShares":12402686,"shares":30255400,"eps":-5.79826,"marketStatus":"Market Closed","change":-0.19,"latestTime":"08-21 16:00:00 EDT","open":10.35,"high":10.69,"low":10,"amount":1681485.071552,"amplitude":0.067449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.79826,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1466568000000,"exchange":"NASDAQ","adjPreClose":10.23,"preHourTrading":{"tag":"盘前","latestPrice":10.45,"preClose":10.23,"latestTime":"09:04 EDT","volume":504,"amount":5166.399672,"timestamp":1787317441899,"change":0.22,"changeRate":0.021505,"amplitude":0.144673},"postHourTrading":{"tag":"盘后","latestPrice":10.04,"preClose":10.04,"latestTime":"19:37 EDT","volume":482,"amount":4850.16,"timestamp":1787355428409,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8620963504397965,"impliedVol":0.5541,"impliedVolPercentile":0.2829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAC\",,,,,undefined,":{"symbol":"RNAC","floatShares":12402686,"roa":"-17.43%","roe":"-7029.26%","lyrEps":-5.02,"volumeRatio":0.8620963504397965,"shares":30255400,"dividePrice":0,"high":10.69,"amplitude":0.067449,"preClose":10.23,"low":10,"week52Low":5.6,"pbRate":"-2.43","psRate":"205.66","week52High":11.8,"institutionHeld":0,"latestPrice":10.04,"eps":-5.79826,"divideRate":0,"volume":163904,"delay":0,"ttmEps":-5.79826,"open":10.35,"prevYearClose":7.21,"prevWeekClose":8.84,"prevMonthClose":7.8,"prevQuarterClose":10.42,"fiveDayClose":8.84,"twentyDayClose":7.88,"sixtyDayClose":6.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"RNAC","fiscalQuarterEnding":"2026/06","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":0.46},{"market":"US","date":"2026-04-30","symbol":"RNAC","fiscalQuarterEnding":"2026/03","expectedEps":-0.84,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":-1.46},{"market":"US","date":"2026-03-09","symbol":"RNAC","fiscalQuarterEnding":"2025/12","expectedEps":-0.82,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-1.38},{"market":"US","date":"2025-11-06","symbol":"RNAC","fiscalQuarterEnding":"2025/09","expectedEps":-0.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.38},{"market":"US","date":"2025-08-07","symbol":"RNAC","fiscalQuarterEnding":"2025/06","expectedEps":-0.76,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1777608000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAC","date":"2026-08-21","current":-1.731554,"percent":0.528271,"low":-14.109752,"twenty":-6.643213,"median":-2.087161,"eighty":-1.488739,"high":-0.322359,"avg":-3.646287,"sd":2.876251,"marketCap":309512250},"quantilePoints":[{"date":"2024-02-09","current":-12.195228,"twenty":-12.293822,"median":-12.139657,"eighty":-11.530164,"marketCap":110159496},{"date":"2024-02-16","current":-13.543282,"twenty":-12.82193,"median":-12.371802,"eighty":-12.018117,"marketCap":122336468},{"date":"2024-02-23","current":-12.9069,"twenty":-13.170416,"median":-12.72226,"eighty":-12.169773,"marketCap":116588031},{"date":"2024-03-01","current":-13.113052,"twenty":-13.187625,"median":-12.9069,"eighty":-12.193077,"marketCap":118450201},{"date":"2024-03-08","current":-0.474472,"twenty":-13.096919,"median":-12.72226,"eighty":-12.104521,"marketCap":104246325},{"date":"2024-03-15","current":-0.394571,"twenty":-13.085087,"median":-12.369113,"eighty":-0.499332,"marketCap":86691095},{"date":"2024-03-22","current":-0.518772,"twenty":-13.077916,"median":-12.18985,"eighty":-0.473381,"marketCap":113979437},{"date":"2024-03-28","current":-0.486782,"twenty":-13.018401,"median":-12.095738,"eighty":-0.472836,"marketCap":106950867},{"date":"2024-04-05","current":-0.371573,"twenty":-12.924109,"median":-11.522994,"eighty":-0.462369,"marketCap":81638284},{"date":"2024-04-12","current":-1.459867,"twenty":-12.9069,"median":-1.226402,"eighty":-0.444134,"marketCap":320747357},{"date":"2024-04-19","current":-1.398365,"twenty":-12.846668,"median":-1.459867,"eighty":-0.462369,"marketCap":307234719},{"date":"2024-04-26","current":-1.691309,"twenty":-12.729072,"median":-1.487381,"eighty":-0.467868,"marketCap":371597548},{"date":"2024-05-03","current":-1.978779,"twenty":-12.63227,"median":-1.536745,"eighty":-0.471303,"marketCap":434757574},{"date":"2024-05-10","current":-1.526348,"twenty":-12.47667,"median":-1.594687,"eighty":-0.472836,"marketCap":389021718},{"date":"2024-05-17","current":-1.839158,"twenty":-12.299559,"median":-1.62026,"eighty":-0.47633,"marketCap":468748036},{"date":"2024-05-24","current":-1.777713,"twenty":-12.193077,"median":-1.671483,"eighty":-0.482182,"marketCap":453087509},{"date":"2024-05-31","current":-2.195259,"twenty":-12.18985,"median":-1.697348,"eighty":-0.489671,"marketCap":559507906},{"date":"2024-06-07","current":-2.422885,"twenty":-12.179811,"median":-1.717665,"eighty":-0.504164,"marketCap":617523039},{"date":"2024-06-14","current":-2.045138,"twenty":-12.139657,"median":-1.777713,"eighty":-0.515905,"marketCap":521246392},{"date":"2024-06-21","current":-1.598266,"twenty":-12.069386,"median":-1.728138,"eighty":-0.518199,"marketCap":407351653},{"date":"2024-06-28","current":-1.991374,"twenty":-11.947846,"median":-1.777713,"eighty":-0.520305,"marketCap":507543431},{"date":"2024-07-05","current":-1.23169,"twenty":-11.531957,"median":-1.728138,"eighty":-0.526438,"marketCap":313922113},{"date":"2024-07-12","current":-1.241477,"twenty":-11.522994,"median":-1.709478,"eighty":-0.530124,"marketCap":316416386},{"date":"2024-07-15","current":-1.240079,"twenty":-9.729226,"median":-1.703386,"eighty":-0.53751,"marketCap":316060062},{"date":"2024-08-02","current":-1.081399,"twenty":-7.935458,"median":-1.699966,"eighty":-0.544895,"marketCap":275617201},{"date":"2024-08-09","current":-1.198323,"twenty":-2.548847,"median":-1.676743,"eighty":-0.772791,"marketCap":275192581},{"date":"2024-08-16","current":-1.345437,"twenty":-2.529995,"median":-1.625846,"eighty":-1.101689,"marketCap":308976908},{"date":"2024-08-23","current":-1.244878,"twenty":-2.507232,"median":-1.598266,"eighty":-1.148418,"marketCap":285883824},{"date":"2024-08-30","current":-1.388267,"twenty":-2.46827,"median":-1.531547,"eighty":-1.172903,"marketCap":318812851},{"date":"2024-09-06","current":-1.307262,"twenty":-2.424002,"median":-1.519153,"eighty":-1.173531,"marketCap":300210089},{"date":"2024-09-13","current":-1.496275,"twenty":-2.390626,"median":-1.497092,"eighty":-1.177113,"marketCap":343616533},{"date":"2024-09-20","current":-1.540036,"twenty":-2.248325,"median":-1.497406,"eighty":-1.182548,"marketCap":353666301},{"date":"2024-09-27","current":-1.616387,"twenty":-2.173184,"median":-1.49772,"eighty":-1.183457,"marketCap":371199939},{"date":"2024-10-04","current":-2.374287,"twenty":-2.173184,"median":-1.519153,"eighty":-1.187433,"marketCap":545250240},{"date":"2024-10-11","current":-2.176603,"twenty":-2.352646,"median":-1.530726,"eighty":-1.193387,"marketCap":499852543},{"date":"2024-10-18","current":-2.257757,"twenty":-2.310612,"median":-1.544226,"eighty":-1.200277,"marketCap":518489492},{"date":"2024-10-25","current":-2.299664,"twenty":-2.339564,"median":-1.569114,"eighty":-1.208188,"marketCap":528113202},{"date":"2024-10-31","current":-2.199769,"twenty":-2.325678,"median":-1.616387,"eighty":-1.208566,"marketCap":505172538},{"date":"2024-11-08","current":-2.028231,"twenty":-2.320475,"median":-1.625846,"eighty":-1.217877,"marketCap":496569789},{"date":"2024-11-15","current":-1.766791,"twenty":-2.31186,"median":-1.676743,"eighty":-1.221601,"marketCap":432561563},{"date":"2024-11-22","current":-1.725268,"twenty":-2.307988,"median":-1.693927,"eighty":-1.221601,"marketCap":422395604},{"date":"2024-11-29","current":-1.954681,"twenty":-2.306323,"median":-1.709478,"eighty":-1.229672,"marketCap":478562529},{"date":"2024-12-06","current":-2.388593,"twenty":-2.306323,"median":-1.725268,"eighty":-1.23169,"marketCap":584796802},{"date":"2024-12-13","current":-2.088591,"twenty":-2.321516,"median":-1.757967,"eighty":-1.238401,"marketCap":511347747},{"date":"2024-12-20","current":-2.024787,"twenty":-2.313583,"median":-1.76875,"eighty":-1.241197,"marketCap":495726646},{"date":"2024-12-27","current":-2.088883,"twenty":-2.309537,"median":-1.777713,"eighty":-1.243092,"marketCap":511419083},{"date":"2025-01-03","current":-1.778913,"twenty":-2.307156,"median":-1.777862,"eighty":-1.244452,"marketCap":435529430},{"date":"2025-01-10","current":-1.777862,"twenty":-2.305849,"median":-1.777862,"eighty":-1.244878,"marketCap":435272177},{"date":"2025-01-17","current":-1.989062,"twenty":-2.304427,"median":-1.779554,"eighty":-1.246554,"marketCap":486980042},{"date":"2025-01-24","current":-2.040548,"twenty":-2.299664,"median":-1.784789,"eighty":-1.253258,"marketCap":499585442},{"date":"2025-01-31","current":-2.036345,"twenty":-2.283748,"median":-1.80308,"eighty":-1.272811,"marketCap":498556430},{"date":"2025-02-07","current":-1.976453,"twenty":-2.276485,"median":-1.8278,"eighty":-1.28026,"marketCap":483893005},{"date":"2025-02-14","current":-1.999569,"twenty":-2.273364,"median":-1.845442,"eighty":-1.299813,"marketCap":489552573},{"date":"2025-02-21","current":-2.060513,"twenty":-2.263946,"median":-1.859179,"eighty":-1.303538,"marketCap":504473250},{"date":"2025-02-28","current":-1.892393,"twenty":-2.258524,"median":-1.87682,"eighty":-1.306703,"marketCap":463312761},{"date":"2025-03-07","current":-1.875581,"twenty":-2.211367,"median":-1.875581,"eighty":-1.307262,"marketCap":459196712},{"date":"2025-03-14","current":-5.557927,"twenty":-2.211367,"median":-1.881886,"eighty":-1.317995,"marketCap":430316947},{"date":"2025-03-21","current":-5.33039,"twenty":-2.277938,"median":-1.88594,"eighty":-1.323353,"marketCap":412700118},{"date":"2025-03-28","current":-4.805047,"twenty":-2.306323,"median":-1.893969,"eighty":-1.325512,"marketCap":372025970},{"date":"2025-04-04","current":-4.129128,"twenty":-2.32984,"median":-1.905491,"eighty":-1.337057,"marketCap":319693626},{"date":"2025-04-11","current":-3.466594,"twenty":-2.375387,"median":-1.926854,"eighty":-1.34432,"marketCap":268397566},{"date":"2025-04-17","current":-3.536863,"twenty":-2.423443,"median":-1.931271,"eighty":-1.357169,"marketCap":273838057},{"date":"2025-04-25","current":-4.03209,"twenty":-2.511189,"median":-1.940728,"eighty":-1.376163,"marketCap":312180567},{"date":"2025-05-02","current":-4.105705,"twenty":-2.552358,"median":-1.945456,"eighty":-1.384171,"marketCap":317880129},{"date":"2025-05-09","current":-7.05935,"twenty":-3.360856,"median":-1.954681,"eighty":-1.385102,"marketCap":270443712},{"date":"2025-05-16","current":-7.066125,"twenty":-3.485332,"median":-1.967259,"eighty":-1.38715,"marketCap":270703255},{"date":"2025-05-23","current":-6.195562,"twenty":-3.649293,"median":-1.975402,"eighty":-1.394326,"marketCap":237351991},{"date":"2025-05-30","current":-6.774808,"twenty":-3.931706,"median":-1.977504,"eighty":-1.416672,"marketCap":259542910},{"date":"2025-06-06","current":-6.327671,"twenty":-4.025398,"median":-1.983808,"eighty":-1.446219,"marketCap":242413077},{"date":"2025-06-13","current":-6.937404,"twenty":-4.149205,"median":-1.989062,"eighty":-1.451731,"marketCap":265771939},{"date":"2025-06-20","current":-6.774808,"twenty":-4.316511,"median":-1.991374,"eighty":-1.456219,"marketCap":259542910},{"date":"2025-06-27","current":-7.76393,"twenty":-4.826462,"median":-1.999044,"eighty":-1.463428,"marketCap":297436174},{"date":"2025-07-03","current":-7.59456,"twenty":-4.979046,"median":-2.003247,"eighty":-1.47767,"marketCap":290947602},{"date":"2025-07-11","current":-9.173091,"twenty":-5.33039,"median":-2.020584,"eighty":-1.478169,"marketCap":351421100},{"date":"2025-07-18","current":-8.488835,"twenty":-5.941507,"median":-2.024838,"eighty":-1.490688,"marketCap":325207266},{"date":"2025-07-25","current":-9.118892,"twenty":-6.287022,"median":-2.028231,"eighty":-1.49255,"marketCap":349344756},{"date":"2025-08-01","current":-8.67853,"twenty":-6.612213,"median":-2.031821,"eighty":-1.496275,"marketCap":332474467},{"date":"2025-08-08","current":-7.544353,"twenty":-6.70706,"median":-2.036345,"eighty":-1.497092,"marketCap":273558227},{"date":"2025-08-15","current":-8.196452,"twenty":-6.774808,"median":-2.042843,"eighty":-1.49772,"marketCap":297203340},{"date":"2025-08-22","current":-7.859415,"twenty":-6.950953,"median":-2.051056,"eighty":-1.50093,"marketCap":284982380},{"date":"2025-08-29","current":-7.371787,"twenty":-7.039026,"median":-2.060422,"eighty":-1.518941,"marketCap":267300991},{"date":"2025-09-05","current":-7.170999,"twenty":-7.05935,"median":-2.070182,"eighty":-1.51928,"marketCap":260020420},{"date":"2025-09-12","current":-7.142315,"twenty":-7.086783,"median":-2.081446,"eighty":-1.524951,"marketCap":258980338},{"date":"2025-09-19","current":-7.3933,"twenty":-7.086783,"median":-2.084663,"eighty":-1.52985,"marketCap":268081053},{"date":"2025-09-26","current":-6.783765,"twenty":-7.148052,"median":-2.088591,"eighty":-1.535541,"marketCap":245979317},{"date":"2025-10-03","current":-7.414813,"twenty":-7.201117,"median":-2.095187,"eighty":-1.539378,"marketCap":268861114},{"date":"2025-10-10","current":-7.242709,"twenty":-7.224056,"median":-2.14643,"eighty":-1.54674,"marketCap":262620624},{"date":"2025-10-17","current":-6.755081,"twenty":-7.209722,"median":-2.173618,"eighty":-1.557355,"marketCap":244939235},{"date":"2025-10-24","current":-6.453899,"twenty":-7.201117,"median":-2.199769,"eighty":-1.567209,"marketCap":234018378},{"date":"2025-10-31","current":-5.81568,"twenty":-7.176736,"median":-2.267478,"eighty":-1.592436,"marketCap":210876560},{"date":"2025-11-07","current":-4.091695,"twenty":-7.170999,"median":-2.283748,"eighty":-1.612763,"marketCap":196315417},{"date":"2025-11-14","current":-3.918507,"twenty":-7.148052,"median":-2.305763,"eighty":-1.619485,"marketCap":188006071},{"date":"2025-11-21","current":-3.875149,"twenty":-7.086783,"median":-2.31186,"eighty":-1.622774,"marketCap":185925782},{"date":"2025-11-28","current":-4.059422,"twenty":-7.068835,"median":-2.325678,"eighty":-1.626335,"marketCap":194767008},{"date":"2025-12-05","current":-3.739654,"twenty":-7.06451,"median":-2.365337,"eighty":-1.65105,"marketCap":179424881},{"date":"2025-12-12","current":-4.579722,"twenty":-7.060984,"median":-2.379788,"eighty":-1.672535,"marketCap":219730470},{"date":"2025-12-19","current":-3.988965,"twenty":-7.05935,"median":-2.423583,"eighty":-1.677012,"marketCap":191386540},{"date":"2025-12-26","current":-3.663777,"twenty":-7.058115,"median":-2.483579,"eighty":-1.682838,"marketCap":175784376},{"date":"2026-01-02","current":-3.907668,"twenty":-7.055526,"median":-2.5116,"eighty":-1.692356,"marketCap":187485999},{"date":"2026-01-09","current":-4.400869,"twenty":-7.049866,"median":-2.540887,"eighty":-1.697913,"marketCap":211149280},{"date":"2026-01-16","current":-3.988965,"twenty":-7.038171,"median":-2.581927,"eighty":-1.705823,"marketCap":191386540},{"date":"2026-01-23","current":-4.1082,"twenty":-7.03475,"median":-3.265826,"eighty":-1.71557,"marketCap":197107333},{"date":"2026-01-30","current":-3.783013,"twenty":-7.03475,"median":-3.400258,"eighty":-1.717665,"marketCap":181505169},{"date":"2026-02-06","current":-3.403628,"twenty":-7.025476,"median":-3.463248,"eighty":-1.725268,"marketCap":163302645},{"date":"2026-02-13","current":-3.474085,"twenty":-7.020408,"median":-3.474085,"eighty":-1.728138,"marketCap":166683114},{"date":"2026-02-20","current":-3.674617,"twenty":-7.019042,"median":-3.506604,"eighty":-1.751586,"marketCap":176304448},{"date":"2026-02-27","current":-4.525524,"twenty":-6.997119,"median":-3.520153,"eighty":-1.758278,"marketCap":217130110},{"date":"2026-03-06","current":-3.728815,"twenty":-6.991626,"median":-3.536863,"eighty":-1.76513,"marketCap":178904809},{"date":"2026-03-13","current":-1.651957,"twenty":-6.985963,"median":-3.528282,"eighty":-1.753846,"marketCap":215253274},{"date":"2026-03-20","current":-1.33662,"twenty":-6.957673,"median":-3.51344,"eighty":-1.717246,"marketCap":174164287},{"date":"2026-03-27","current":-1.236933,"twenty":-6.943412,"median":-3.490344,"eighty":-1.689135,"marketCap":161174865},{"date":"2026-04-02","current":-1.3,"twenty":-6.939053,"median":-3.46763,"eighty":-1.672535,"marketCap":169392663},{"date":"2026-04-10","current":-1.257277,"twenty":-6.933339,"median":-3.403628,"eighty":-1.622146,"marketCap":163825768},{"date":"2026-04-17","current":-1.297966,"twenty":-6.92426,"median":-3.364537,"eighty":-1.565304,"marketCap":169127573},{"date":"2026-04-24","current":-1.417997,"twenty":-6.914189,"median":-2.609701,"eighty":-1.534337,"marketCap":184767897},{"date":"2026-05-01","current":-1.086392,"twenty":-6.894617,"median":-2.546025,"eighty":-1.512742,"marketCap":164886129},{"date":"2026-05-08","current":-1.579672,"twenty":-6.838981,"median":-2.513656,"eighty":-1.499646,"marketCap":239753154},{"date":"2026-05-15","current":-1.600967,"twenty":-6.793804,"median":-2.483579,"eighty":-1.502438,"marketCap":242985120},{"date":"2026-05-22","current":-1.293163,"twenty":-6.778391,"median":-2.422885,"eighty":-1.494785,"marketCap":196268513},{"date":"2026-05-29","current":-1.395764,"twenty":-6.774808,"median":-2.379788,"eighty":-1.483177,"marketCap":211840715},{"date":"2026-06-05","current":-1.267997,"twenty":-6.772654,"median":-2.365337,"eighty":-1.459736,"marketCap":192448916},{"date":"2026-06-12","current":-1.560313,"twenty":-6.766157,"median":-2.325678,"eighty":-1.446219,"marketCap":236815002},{"date":"2026-06-18","current":-1.912642,"twenty":-6.761259,"median":-2.31186,"eighty":-1.450539,"marketCap":290289358},{"date":"2026-06-26","current":-1.728734,"twenty":-6.760023,"median":-2.305763,"eighty":-1.456175,"marketCap":262376920},{"date":"2026-07-02","current":-1.970718,"twenty":-6.755081,"median":-2.291706,"eighty":-1.459648,"marketCap":299103812},{"date":"2026-07-10","current":-1.871989,"twenty":-6.755081,"median":-2.273364,"eighty":-1.459867,"marketCap":284119240},{"date":"2026-07-17","current":-1.612582,"twenty":-6.70706,"median":-2.228763,"eighty":-1.46072,"marketCap":244748011},{"date":"2026-07-24","current":-1.533211,"twenty":-6.70706,"median":-2.176603,"eighty":-1.47767,"marketCap":232701590},{"date":"2026-07-31","current":-1.49643,"twenty":-6.688109,"median":-2.155028,"eighty":-1.47428,"marketCap":227119103},{"date":"2026-08-07","current":-1.694518,"twenty":-6.664384,"median":-2.120969,"eighty":-1.478069,"marketCap":257382062},{"date":"2026-08-14","current":-1.736947,"twenty":-6.655677,"median":-2.088883,"eighty":-1.480388,"marketCap":263826669},{"date":"2026-08-21","current":-2.037726,"twenty":-6.643213,"median":-2.087161,"eighty":-1.488739,"marketCap":309512250}],"updateTime":1787490691027},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660890460","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660890460","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660890460?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:50","pubTimestamp":1787057407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DocGo (DCGO) and Cartesian Therapeutics (RNAC) with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-304?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-304?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC","DCGO","BK4196","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467927","title":"Cartesian Therapeutics Price Target Maintained with a $38.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467927","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467927?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:45","pubTimestamp":1787057100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNAC/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657236376","title":"Cantor Fitzgerald Keeps Their Buy Rating on Cartesian Therapeutics (RNAC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657236376","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657236376?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:26","pubTimestamp":1786127164,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Kristen Kluska reiterated a Buy rating on Cartesian Therapeutics yesterday and set a price target of $16.00. According to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-cartesian-therapeutics-rnac-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-cartesian-therapeutics-rnac-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657617004","title":"Cartesian Therapeutics Grants New Hires Stock Options for 115,250 Shares Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2657617004","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657617004?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100419,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics grants new hires stock options for 115,250 shares under inducement planCartesian Therapeutics granted inducement stock options covering 115,250 shares to four newly hired employ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL3FZBs1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BCDF","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4139","RNAC","IE00BN0W2V16.EUR","BK4112","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657437656","title":"Cartesian Therapeutics Announces New Employment Inducement Grants","url":"https://stock-news.laohu8.com/highlight/detail?id=2657437656","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657437656?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100400,"startTime":"0","endTime":"0","summary":"FREDERICK, Md., Aug.  07, 2026  (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune dise","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/07/3341020/0/en/cartesian-therapeutics-announces-new-employment-inducement-grants.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657155296","title":"Cartesian Therapeutics: Late-Stage Descartes-08 De-Risking and 2027 Data Wave Underpin Van Buren’s Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657155296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657155296?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:08","pubTimestamp":1786090086,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on RNAC stock, giving a Buy rating yesterday. Tyler Van Buren has given his Bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cartesian-therapeutics-late-stage-descartes-08-de-risking-and-2027-data-wave-underpin-van-burens-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cartesian-therapeutics-late-stage-descartes-08-de-risking-and-2027-data-wave-underpin-van-burens-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DSGX","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657740","title":"Lineage Cell Therapeutics Q2 Revenue Falls but Posts Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657740","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657740?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:11","pubTimestamp":1786047092,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Q2 revenue falls but posts profitOverviewUS cell therapy developer's Q2 revenue declined yr/yr due to lower collaboration revenueQ2 net income reached $1.5 mln, reversing a l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","BK4585","NTLA","BK4556","LU1861559042.SGD","RNAC","BK4535","LU1861558580.USD","DTIL","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634108","title":"Cartesian Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634108","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634108?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:02","pubTimestamp":1786021348,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryCartesian Therapeutics, Inc.RNAC.OQreported quarterly adjusted earnings of 64 cents per share for the quart","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4431RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657363993","title":"Cartesian Therapeutics Q2 2026 earnings: R&D spending rises as Phase 3 advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2657363993","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657363993?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:52","pubTimestamp":1786017154,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics reported no revenue for Q2 2026, versus $0.3 million a year earlier, while diluted EPS eased to $0.46 from $0.50. R&D expense climbed to $20.4 million as Phase 3 AURORA advanced, widening operating loss to $29.2 million. Net income of $15.8 million was supported by a $49.2 million fair-value gain on contingent value rights. Cash, cash equivalents and restricted cash totaled $149.3 million at June 30, and the company expects resources to support operations into 2028, with AURORA data expected in Q1 2027.","market":"nz","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock7.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock7.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262083388-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JOYT","DECU","GXDW","PMDE","VOTE","RGLO","FEBU","VGFPF","LRND","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563315","title":"Cartesian Therapeutics Q2 EPS $0.46 Beats $(0.86) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563315","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657563315?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:26","pubTimestamp":1786015571,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics (NASDAQ:RNAC) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $(0.86) by 153.49 percent. This is a 8 percent decrease over earnings of $0.50 per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60988802/cartesian-therapeutics-q2-eps-0-46-beats-0-86-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657254638","title":"Cartesian Therapeutics Q2 FY26 Net Income Slips 0.74% to $15.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657254638","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657254638?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:10","pubTimestamp":1786014629,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics Q2 FY26 net income slips 0.74% to $15.8 millionCartesian Therapeutics posted Q2 net income of USD 15.8 million, down 0.7% year over year; GAAP EPS slipped to USD 0.47 from USD 0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL85HBgh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657804676","title":"Cartesian Therapeutics Inc Q2 Operating Income USD -29.155 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657804676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657804676?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014007,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXVJTL35:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657605633","title":"Cartesian Therapeutics: Phase 3 Aurora Trial of Descartes-08 in Myasthenia Gravis Data Expected in 1Q27, Bla Planned for Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2657605633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657605633?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXVJTL35:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657800996","title":"Press Release: Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657800996","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657800996?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014000,"startTime":"0","endTime":"0","summary":"Expected in 1Q27, with BLA Planned for Mid-2027. The randomized,double-blind, placebo-controlled Phase 3 AURORA trial is designed to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B19Z4B17.USD","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4123","IE0031619046.USD","MG","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656737970","title":"Cartesian Therapeutics Inc Expected to Post a Loss of 87 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656737970","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656737970?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:42","pubTimestamp":1785760925,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics Inc <RNAC.OQ> expected to post a loss of87cents a share - Earnings PreviewCartesian Therapeutics IncRNAC.OQRNAC.Ois expected to  show a fall in quarterly revenue when it reports","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N44018M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501064","title":"Cartesian Therapeutics Grants Inducement Stock Options for 238,700 Shares at $10.18 to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501064","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648501064?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:05","pubTimestamp":1782990310,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics grants inducement stock options for 238,700 shares at $10.18 to new hiresCartesian Therapeutics issued stock options covering 238,700 shares to eight new employees under its 201","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDLbt9X02:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BN0W2T93.GBP","RNAC","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","SG9999014013.SGD","BK4112","LU2095319765.USD","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2V16.EUR","BK4585","IE00BGHQF748.EUR","IE00BN0W2W23.USD","LU2210149790.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504326","title":"Cartesian Therapeutics Announces New Employment Inducement Grants","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504326","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648504326?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:05","pubTimestamp":1782990300,"startTime":"0","endTime":"0","summary":"FREDERICK, Md., July  02, 2026  (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune dise","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/02/3321228/0/en/Cartesian-Therapeutics-Announces-New-Employment-Inducement-Grants.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648106775","title":"Cartesian Therapeutics (RNAC) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2648106775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648106775?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:35","pubTimestamp":1782905756,"startTime":"0","endTime":"0","summary":"In a report released today, Julian Harrison from BTIG reiterated a Buy rating on Cartesian Therapeutics, with a price target of $44.00. Harrison co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cartesian-therapeutics-rnac-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cartesian-therapeutics-rnac-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644722131","title":"Cartesian Therapeutics Shareholders Back Directors and Governance Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2644722131","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644722131?lang=en_us&edition=fundamental","pubTime":"2026-06-18 05:53","pubTimestamp":1781733190,"startTime":"0","endTime":"0","summary":"The latest update is out from Cartesian Therapeutics ( ($RNAC) ). On June 12, 2026, Cartesian Therapeutics, Inc. held its 2026 Annual Meeting of St...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cartesian-therapeutics-shareholders-back-directors-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cartesian-therapeutics-shareholders-back-directors-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644729601","title":"Cartesian Therapeutics shareholders elect Class I director slate at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644729601","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644729601?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:02","pubTimestamp":1781726524,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics held its annual shareholder meeting on June 12, 2026.Shareholders selected three Class I directors to serve through the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL50Cn8w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":78,"code":"91000000","status":"200"}]}}